Electronic State Business Daily Search
Sign in is NOT required.
For instructions on submitting bid responses, please review the posting entity’s solicitation and attached
bid documents.
RFP for Opioid Use Disorder Treatment Medications |
Solicitation ID: R2270-2023-7
Status: Addendum Posted
Contact Name: Brody Ballard
Contact Number: 512-440-4022
Contact Email: Brody.Ballard@Integralcare.org
Response Due Time: 5:00 PM
Agency/Texas SmartBuy Member Number: R2270
Days Solicited: 21+ Days for Solicitation Notice
Solicitation Posting Date: 11/14/2023
Response Due Date: 12/19/2023
Last Modified: 11/14/2023 2:48 pm
Solicitation Description:
Integral Care is soliciting proposals for SALE OF OPOIOD USE DISORDER TREATMENT MEDICATIONS (INCLUDING METHADONE, BUPRENORPHINE AND BUPRENORPHINE/NALOXONE). The Request for Proposals may be accessed beginning November 14, 2023. The deadline to submit a proposal under the RFP is 5:00 p.m. CDT on December 19, 2023. Historically Underutilized Businesses, including Minority-Owned Businesses and Women-Owned Businesses, are encouraged to apply.
Class/Item Code(s):
26972-Miscellaneous Drugs And Pharmaceuticals (Not Otherwise Classified)
26987-Therapeutic Agents, Unclassified
Attachments
# | Name | Description |
---|---|---|
1 | ESBD_File_341623_RFP - Opioid Products (11-14-23).docx | RFP Specifications |